Tag: Vertex

Vertex CF Drug Approved for Children

Lumacaftor/ivacaftor is the first and only approved medicine in Europe to treat the underlying cause of cystic fibrosis for approximately 1,500 children aged 2 to 5 with two copies of the F508del muta...

Vertex to File Two Latest Drugs with Scottish Medicines Consortium

Vertex is to file its two latest cystic fibrosis drugs with Scotland’s drug cost watchdog in a bid for NHS reimbursement – but an ongoing row over price in England is still unresolved. The US pharm...

Positive Clinical Data for Vertex Pain Drug

Vertex is far-and-away the leader in cystic fibrosis drugmaking. Three approved therapies collectively raked in more than $2.1 billion this year, and the biotech is rapidly progressing with triple-com...

Vertex constructs the third stage of the pharma complex for 2.3 billion rubles

Pharmaceutical company VERTEX is now constructing the third stage of the Innovation and Production Complex in the Novoorlovskaya site, Special Economic Zone Saint-Petersburg.

Pharmaceutical companies are actively investing in St. Petersburg SEZ

st petersburg sez
Since the beginning of 2018, the residents of St. Petersburg Special Economic Zone (SEZ) have invested 1.787 billion rubles in their projects. Over the same period of last year, the residents invested 1.537 billion rubles.

VERTEX is building the second stage of its pharmaceutical facility

VERTEX, a pharmaceutical company, is engaged in the construction of a laboratory and warehouse building, the second stage of its innovation and production facility on Novoorlovskaya site in St. Petersburg Special Economic Zone.

VERTEX increased its output of Russian medicines by 30%

VERTEX published its official results for 2017. The pharmaceutical company demonstrated growth in four areas, including the output, number of pharmacies selling its products, product range, and revenue.

VERTEX receives the Russian Government Quality Award

VERTEX, a pharmaceutical company, was among ten winners of the 2017 Russian Government Quality Award.

VERTEX manufactured 2 billion tablets and capsules in 2 years

In two years following the launch of the pharmaceutical plant in late August 2015, VERTEX manufactured more than 100 million packages of drugs at this new site